血清神经丝轻链:早期糖尿病感觉运动多发性神经病变的新型生物标志物
本研究为德国糖尿病研究前瞻性观察队列的横断面分析,纳入423例病程不足1年的1型和2型糖尿病成人,发现16%存在糖尿病感觉运动多发性神经病变(DSPN)。校正多种混杂因素后,血清神经丝轻链(NFL)每升高1个归一化蛋白表达单位,DSPN风险比为1.92(95%CI 1.50–2.45,p<0.0001),并与神经传导速度减慢等神经功能指标相关。
要点
- 在病程不足1年的糖尿病患者中,血清NFL升高与DSPN患病风险独立相关(RR 1.92,95%CI 1.50–2.45)。
- 血清NFL升高与运动及感觉神经传导速度减慢、腓肠感觉神经动作电位降低相关。
- 其他神经生物标志物与DSPN或神经功能指标未见关联证据。
核心结论
- 在近期诊断为糖尿病的个体中,较高的血清NFL水平与DSPN及周围神经功能障碍相关,本研究支持NFL作为DSPN的潜在生物标志物。
研究设计与样本
- 横断面研究,纳入德国糖尿病研究前瞻性观察队列中423例病程不足1年的1型和2型糖尿病成人。
- 采用邻近延伸分析技术多重检测空腹血清NFL,DSPN按多伦多共识标准定义,通过神经学检查、神经传导研究和定量感觉测试评估。
主要发现
- 研究样本中DSPN患病率为16%。
- 血清NFL水平随年龄增长而升高。
- 校正年龄、性别、腰围、身高、HbA1c、已知糖尿病病程、糖尿病类型、胆固醇、eGFR、高血压、CVD、降脂药使用和非甾体抗炎药使用后,血清NFL每升高1个归一化蛋白表达单位与DSPN相关(RR 1.92,95%CI 1.50–2.45,p<0.0001)。
- 血清NFL升高与运动神经传导速度减慢(均p<0.0001)、感觉神经传导速度减慢(均p≤0.03)、腓肠感觉神经动作电位降低(p=0.0004)以及手和足热刺激温度察觉阈值升高(分别为p=0.023和p=0.004)相关。
- 其他神经生物标志物与DSPN或神经功能指标之间未见关联证据。
关键数值与推荐
- DSPN按多伦多共识标准定义。
- 血清NFL与DSPN的关联以Poisson回归估计,效应量为RR 1.92(95%CI 1.50–2.45,p<0.0001),对应血清NFL每升高1个归一化蛋白表达单位。
临床怎么用
- 原文结论认为NFL可作为DSPN的潜在生物标志物,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: No established blood-based biomarker exists to monitor diabetic sensorimotor polyneuropathy (DSPN) and evaluate treatment response. The neurofilament light chain (NFL), a blood biomarker of neuroaxonal damage in several neurodegenerative diseases, represents a potential biomarker for DSPN. We hypothesised that higher serum NFL levels are associated with prevalent DSPN and nerve dysfunction in individuals recently diagnosed with diabetes. METHODS: This cross-sectional study included 423 adults with type 1 and type 2 diabetes and known diabetes duration of less than 1 year from the prospective observational German Diabetes Study cohort. NFL was measured in serum samples of fasting participants in a multiplex approach using proximity extension assay technology. DSPN was assessed by neurological examination, nerve conduction studies and quantitative sensory testing. Associations of serum NFL with DSPN (defined according to the Toronto Consensus criteria) were estimated using Poisson regression, while multivariable linear and quantile regression models were used to assess associations with nerve function measures. In exploratory analyses, other biomarkers in the multiplex panel were also analysed similarly to NFL. RESULTS: DSPN was found in 16% of the study sample. Serum NFL levels increased with age. After adjustment for age, sex, waist circumference, height, HbA1c, known diabetes duration, diabetes type, cholesterol, eGFR, hypertension, CVD, use of lipid-lowering drugs and use of non-steroidal anti-inflammatory drugs, higher serum NFL levels were associated with DSPN (RR [95% CI] per 1-normalised protein expression increase, 1.92 [1.50, 2.45], p<0.0001), slower motor (all p<0.0001) and sensory (all p≤0.03) nerve conduction velocities, lower sural sensory nerve action potential (p=0.0004) and higher thermal detection threshold to warm stimuli (p=0.023 and p=0.004 for hand and foot, respectively). There was no evidence for associations between other neurological biomarkers and DSPN or nerve function measures. CONCLUSIONS/INTERPRETATION: Our findings in individuals recently diagnosed with diabetes provide new evidence associating higher serum NFL levels with DSPN and peripheral nerve dysfunction. The present study advocates NFL as a potential biomarker for DSPN.
引用
- Maalmi H, Strom A, Petrera A, et al. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia. 2022. PMID: 36472640. doi:10.1007/s00125-022-05846-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。